论文部分内容阅读
目的探讨实验室激素检查联合彩超诊断甲状腺癌临床应用价值。方法以2012年1月~2013年12月期间在我院接受治疗45例甲状腺癌患者为研究对象,并将其随机分配使用彩超诊断的A组和使用彩超联合促甲状腺激素诊断的B组,其中A组患者中有25例患者,B组中有20例患者,然后对两组患者的甲状腺癌诊断准确率进行比较。结果只是单独使用彩超的A组甲状腺癌患者的诊断率是56.0%,具体来说有14例患者被确诊为甲状腺癌,6例良恶性甲状腺未被确诊,另外还有5例患者被误诊为良性病变。而B组患者甲状腺癌的诊断率为90.0%,具体来说就是有18例患者被确诊为甲状腺癌,1例未被确诊的良恶性患者和1例被误诊的良性病变患者。结论实验室激素检查联合彩超诊断甲状腺癌能够有效提高甲状腺癌的诊断率,在甲状腺癌的诊断中具有很高的临床推广应用价值。
Objective To investigate the clinical value of laboratory hormone test combined with color Doppler ultrasonography in the diagnosis of thyroid cancer. Methods Forty-five patients with thyroid cancer treated in our hospital from January 2012 to December 2013 were enrolled in this study. They were randomly assigned to Group A, which was diagnosed by color Doppler ultrasound, and Group B, which was diagnosed by thyroid stimulating hormone by color Doppler. Twenty-five patients in group A and 20 patients in group B then compared the diagnostic accuracy of thyroid cancer between the two groups. The result was that the diagnosis rate of thyroid cancer in group A alone was 56.0%. Specifically, 14 cases were diagnosed as thyroid cancer, 6 cases of benign and malignant thyroid were not diagnosed, and 5 cases were misdiagnosed as benign Lesions. The diagnosis rate of thyroid cancer in group B was 90.0%. Specifically, 18 cases were diagnosed as thyroid cancer, one case of undiagnosed benign and malignant cases and one case of misdiagnosed benign lesion. Conclusion Laboratory hormone test combined with color Doppler ultrasound diagnosis of thyroid cancer can effectively improve the diagnostic rate of thyroid cancer in the diagnosis of thyroid cancer has a high clinical application value.